Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. I. Verweij
T-Cell Landscape in a Primary Melanoma Predicts the Survival of Patients With Metastatic Disease After Their Treatment With Dendritic Cell Vaccines
Cancer Research
Cancer Research
Oncology
Related publications
T Cell Landscape Within Primary Melanoma as a Biomarker of Survival After Cancer Vaccination in Patients With Metastatic Disease
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
CD8+ T Cell Responses in Metastatic Melanoma Patients Receiving an Adenovirally Antigen Engineered Dendritic Cell Vaccine +/- IFN-α
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
A Three-Variable Model Predicts Short Survival in Patients With Newly Diagnosed Metastatic Renal Cell Carcinoma
Journal of Clinical Medicine Research
Improved Survival With T Cell Clonotype Stability After Anti-Ctla-4 Treatment in Cancer Patients
Science Translational Medicine
Medicine
Long-Term Survival of Pancreatic Cancer Patients Treated With Multimodal Therapy Combined With WT1-targeted Dendritic Cell Vaccines
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Immunotherapy of Cancer With Dendritic Cell-Based Vaccines
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Twelve-Year Survival and Immune Correlates in Dendritic Cell–vaccinated Melanoma Patients
JCI insight
Medicine
Influence of Metronomic Cyclophosphamide and Interleukine-2 Alone or Combined on Blood Regulatory T Cells in Patients With Advanced Malignant Melanoma Treated With Dendritic Cell Vaccines
Journal of Clinical & Cellular Immunology
Enhanced Survival in Patients With Multiple Primary Melanoma
Archives of Dermatology
